Clinical trial
Effects of Very Low Dose Oral Anticoagulation on Thromboembolism and Bleeding Events in Patients With Mechanical Heart Valve Replacement
NCT00528671 is registered in ClinicalTrials.gov with Heart and Diabetes Center North-Rhine Westfalia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Very Low Dose Oral Anticoagulation on Thromboembolism and Bleeding Events in Patients With Mechanical Heart Valve Replacement
- Lead sponsor
- Heart and Diabetes Center North-Rhine Westfalia
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- January 31, 2006
- Completion date
- November 30, 2013
- Enrollment
- 1,571 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mechanical heart valve recipients